Page last updated: 2024-08-23

bezafibrate and eicosapentaenoic acid

bezafibrate has been researched along with eicosapentaenoic acid in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Barbir, M; Hunt, B; Kehely, A; Kushwaha, S; Mitchell, A; Prescot, R; Thompson, GR; Yacoub, M	1
Awata, T; Inoue, I; Katayama, S; Noji, S; Shino, K	1
Fujioka, Y; Iwasaki, T; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Tsuboi, S; Tsujino, T	1
Nagao, M; Oikawa, S	1

Reviews

1 review(s) available for bezafibrate and eicosapentaenoic acid

Article	Year
[Intervention for hypertriglyceridemia]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Jul-28, Volume: 65 Suppl 7 Topics: Aged; Bezafibrate; Clofibric Acid; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hypertriglyceridemia; Male; Middle Aged; Niacin	2007

Trials

1 trial(s) available for bezafibrate and eicosapentaenoic acid

Article	Year
Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients. The American journal of cardiology, 1992, Dec-15, Volume: 70, Issue:20 Topics: Apolipoprotein A-I; Apolipoproteins B; Bezafibrate; Cholesterol; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Heart Transplantation; Humans; Hyperlipidemias; Lipoprotein(a); Male; Time Factors; Triglycerides	1992

Article

Year

Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients.

The American journal of cardiology, 1992, Dec-15, Volume: 70, Issue:20

Topics: Apolipoprotein A-I; Apolipoproteins B; Bezafibrate; Cholesterol; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Heart Transplantation; Humans; Hyperlipidemias; Lipoprotein(a); Male; Time Factors; Triglycerides

1992

Other Studies

3 other study(ies) available for bezafibrate and eicosapentaenoic acid

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochemical and biophysical research communications, 1998, May-19, Volume: 246, Issue:2 Topics: Aorta; Bezafibrate; Cells, Cultured; Coronary Vessels; Dexamethasone; Eicosapentaenoic Acid; Endothelium, Vascular; Gene Expression; Humans; Hypolipidemic Agents; Insulin; Liver; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors; Umbilical Arteries; Umbilical Veins	1998
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:1 Topics: Animals; Bezafibrate; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Chromans; Diet; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fructose; Hydrogen-Ion Concentration; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Male; Propionates; Rats; Sodium-Hydrogen Exchangers; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasodilator Agents	2003